Back to Search
DAVID FELDMAN, MD
MD
Plastic Surgery Physician
NPI: 1053311431Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors.
PMID 19547919·Invest New Drugs·2010
3-trial
Good-risk-advanced germ cell tumors: historical perspective and current standards of care.
PMID 19513721·World J Urol·2009
6-review
Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.
PMID 19224847·J Clin Oncol·2009
5-case
Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention.
PMID 19494400·J Invasive Cardiol·2009
8-other
Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinoma.
PMID 18501079·Clin Genitourin Cancer·2008
3-trial
Is high-dose chemotherapy effective in patients with relapsed or refractory germ cell tumors?
PMID 18073725·Nat Clin Pract Urol·2008
8-other
Presentation of low back pain in children had a low diagnosis rate.
PMID 18978437·J Bone Joint Surg Am·2008
8-other
Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents.
PMID 17892994·Am Heart J·2007
4-observational
Interobserver and intraobserver reliability in lower-limb deformity correction measurements.
PMID 17314647·J Pediatr Orthop·2007
8-other
Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumors.
PMID 17520176·Invest New Drugs·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 925 49TH ST
BROOKLYN, NY 11219 - Phone
- (718) 283-7022
Quick Facts
- NPI
- 1053311431
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile